CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 102 filers reported holding CHEMOCENTRYX INC in Q3 2019. The put-call ratio across all filers is 0.85 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $403,000 | -99.8% | 7,797 | -99.9% | 0.00% | -100.0% |
| Q2 2022 | $264,624,000 | -0.7% | 10,678,955 | +0.5% | 0.03% | +23.8% |
| Q1 2022 | $266,495,000 | -30.3% | 10,630,004 | +1.2% | 0.02% | -25.0% |
| Q4 2021 | $382,476,000 | +113.3% | 10,504,719 | +0.2% | 0.03% | +100.0% |
| Q3 2021 | $179,303,000 | +28.0% | 10,485,525 | +0.2% | 0.01% | +27.3% |
| Q2 2021 | $140,092,000 | -73.8% | 10,462,435 | +0.2% | 0.01% | -76.1% |
| Q1 2021 | $535,048,000 | -16.8% | 10,441,990 | +0.6% | 0.05% | -19.3% |
| Q4 2020 | $642,808,000 | +13.5% | 10,381,262 | +0.5% | 0.06% | 0.0% |
| Q3 2020 | $566,296,000 | -3.2% | 10,333,873 | +1.7% | 0.06% | -10.9% |
| Q2 2020 | $584,946,000 | +57.4% | 10,165,899 | +9.9% | 0.06% | +25.5% |
| Q1 2020 | $371,532,000 | +7.5% | 9,246,685 | +5.8% | 0.05% | +34.2% |
| Q4 2019 | $345,678,000 | +774.4% | 8,740,285 | +49.9% | 0.04% | +660.0% |
| Q3 2019 | $39,533,000 | -24.9% | 5,830,896 | +3.0% | 0.01% | -16.7% |
| Q2 2019 | $52,668,000 | -34.3% | 5,663,196 | -1.9% | 0.01% | -40.0% |
| Q1 2019 | $80,207,000 | +1041.1% | 5,774,432 | +796.2% | 0.01% | +900.0% |
| Q4 2018 | $7,029,000 | +157.8% | 644,305 | +61.4% | 0.00% | – |
| Q4 2014 | $2,727,000 | +40.1% | 399,200 | +14.1% | 0.00% | – |
| Q3 2013 | $1,946,000 | -45.0% | 350,000 | +40.0% | 0.00% | -100.0% |
| Q2 2013 | $3,535,000 | – | 250,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |